Home › Respiratory Distress Syndrome › Tennessee
Respiratory Distress Syndrome clinical trials in Tennessee
8 studies for Respiratory Distress Syndrome are looking for participants at sites in Tennessee.
Cities in Tennessee
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
- Vanderbilt University Medical Center, Nashville
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT06701669JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
- Vanderbilt University Medical Center, Nashville
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT06701682JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
- Vanderbilt University Medical Center, Nashville
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT06701656JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
- Vanderbilt University Medical Center, Nashville
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT06703073Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)
- Direct Biologics Investigational Site, Knoxville
- Direct Biologics Investigational Site, Nashville
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Feb 23, 2026 · NCT05354141The APS Phenotyping Study
- Meharry Medical College, Nashville
- Vanderbilt University Medical Center, Nashville
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 20, 2026 · NCT06521502Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- The Jackson Clinic, PA, Jackson
RecruitingObservational study
Ages 50 and older · All sexes · Updated Aug 5, 2025 · NCT06122077InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS
- Western TN- Jackson-Madison County General Hospital, Jackson
RecruitingPhase 3
29 Weeks – 36 Weeks · All sexes · Updated Mar 30, 2025 · NCT05960929From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.